Collection
Hepatobiliary & Pancreatic Oncology
Educational content from recorded physician discussions — not medical advice. Always talk to your child's care team about your child's situation.
Content of this collection
R0 resection is associated with decreased expected hazards of experiencing an event (hazard ratio 0.14, 95% confidence interval 0.05-0.38) in multivariate analysis. Management of undifferentiated embryonal sarcoma of the liver: A Pediatric Surgical Oncology Research Collaborative study
Hepatocellular Neoplasms1 item
Histologic type predicts disparate outcomes in pediatric hepatocellular neoplasms: A Pediatric Surgical Oncology Research Collaborative study
Read →
Hepatocellular carcinoma (HCC) is a rare cancer in children, with various histologic subtypes and a paucity of data to guide clinical management and predict prognosis. A multi-institutional review of children with hepatocellular neoplasms w
article · Oct 2026
Hepatoblastoma1 item
Characteristics of Transfusion and Association With Oncologic Outcomes in Hepatoblastoma Resection
Watch →
Stephanie F Polites, Jennifer H Aldrink, Timothy B Lautz, Robert A Vierkant, Mecklin V Ragan, Audra Reiter, Stephanie Y Chen, Eugene S Kim, Hannah N Rinehardt, Marcus M Malek, Andrew M Fleming, Andrew J Murphy, Jonathan P Roach, Sridharan R
video1:10 · Apr 2026
Undifferentiated Embryonal Sarcoma1 item
Management of undifferentiated embryonal sarcoma of the liver: A Pediatric Surgical Oncology Research Collaborative study
Read →
Background: Undifferentiated embryonal sarcoma of the liver (UESL) is a rare tumor for which there are few evidence-based guidelines. The aim of this study was to define current management strategies and outcomes for these patients using a
article · Oct 2026
Pancreaticoduodenectomy for the treatment of pancreatic neoplasms in children: A Pediatric Surgical Oncology Research Collaborative study
Read →
This is the largest series of pediatric PD patients. PD is curative for SPN and benign neoplasms. Pancreatic insufficiency is the most common postoperative complication. Outcome is primarily associated with histology.
article · Oct 2026
Featured picks for families are being prepared — the summaries above are written for you.
Expert statements from the recordings in this collection.
Characteristics of Transfusion and Association With Oncologic Outcomes in Hepatoblastoma Resection
It is not uncommon for a patient with hepatoblastoma to need a transfusion during resection
The study was multi-institutional and published in Pediatric Blood and Cancer in 2025
The study examined how intraoperative transfusion may affect recurrence and survival in hepatoblastoma resection patients
Of those transfused, the majority received red blood cells
Only 11% of transfused patients received platelets
Intraoperative blood transfusions had no effect on recurrence
Intraoperative blood transfusions were associated with increased death
There were instances of unnecessary blood transfusions
Patients who were transfused had higher post-op hemoglobin
Transfused patients still required more plasma and platelets postoperatively
The authors think that blood transfusions were mostly red blood cells, and that is what contributed to the post-op coagulopathy
The authors recommend more careful patient selection for intraoperative transfusions
The authors recommend a balanced transfusion approach
Management of undifferentiated embryonal sarcoma of the liver: A Pediatric Surgical Oncology Research Collaborative study
The median age at presentation for undifferentiated embryonal sarcoma of the liver is 9.9 years (interquartile range 7-12 years).
Cites published research
Twenty-seven patients (35%) underwent resection at diagnosis while 47 patients (60%) underwent delayed resection after neoadjuvant chemotherapy.
Cites published research
Eight patients underwent liver transplantation as part of their surgical management.
Cites published research
Neoadjuvant chemotherapy led to a median change in maximum tumor diameter of 1.6 cm (interquartile range 0.0-4.4 cm).
Cites published research
Greater than 90% tumor necrosis was achieved in 79% of patients undergoing delayed resection after neoadjuvant chemotherapy.
Cites published research
R0 resections were accomplished in 63 patients (81% of the cohort).
Cites published research
Metastatic disease at presentation impacts overall survival in univariate analysis.
Cites published research
Completeness of resection impacts both event-free survival and overall survival in univariate analysis.
Cites published research
R0 resection is associated with decreased expected hazards of experiencing an event (hazard ratio 0.14, 95% confidence interval 0.05-0.38) in multivariate analysis.
Cites published research
